Ion channel modulating compounds and uses thereof

Details Ion channel modulating compounds and uses thereof Ion channel modulating compounds and uses thereof

2006-06-06

2006-06-06

Saeed, Kamal A. (Department: 1626)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S424000

Reexamination Certificate

active

07057053

ABSTRACT:
Ion channel modulating compounds are disclosed. The compounds of the present invention may be incorporated in compositions and kits. The present invention also discloses a variety of in vitro and in vivo uses for the compounds and compositions, including the treatment of arrhythmia and the production of analgesia and local anesthesia.

REFERENCES:
patent: 2954380 (1960-09-01), Shapiro et al.
patent: 3218328 (1965-11-01), Shapiro et al.
patent: 4145435 (1979-03-01), Szmuszkovicz
patent: 4179501 (1979-12-01), Szmuszkovicz
patent: 4598087 (1986-07-01), Horwell
patent: 4656182 (1987-04-01), Horwell
patent: 4663343 (1987-05-01), Horwell et al.
patent: 4855316 (1989-08-01), Horwell et al.
patent: 4880800 (1989-11-01), Wallis
patent: 4906655 (1990-03-01), Horwell et al.
patent: 5019588 (1991-05-01), Horwell et al.
patent: 5051428 (1991-09-01), Horwell et al.
patent: 5059620 (1991-10-01), Stout et al.
patent: 5492825 (1996-02-01), Jan et al.
patent: 5506257 (1996-04-01), MacLeod et al.
patent: 5637583 (1997-06-01), MacLeod et al.
patent: 5670335 (1997-09-01), Jan et al.
patent: 5728535 (1998-03-01), Lester et al.
patent: 5734021 (1998-03-01), Lester et al.
patent: 5750537 (1998-05-01), Nomura et al.
patent: 5817698 (1998-10-01), Brown et al.
patent: 5885984 (1999-03-01), MacLeod et al.
patent: 6174879 (2001-01-01), MacLeod et al.
patent: 6180632 (2001-01-01), Myers et al.
patent: 6210809 (2001-04-01), Okutomi et al.
patent: 6214809 (2001-04-01), Fermini et al.
patent: 6214810 (2001-04-01), Fermini et al.
patent: 6451819 (2002-09-01), Alanine et al.
patent: 6521619 (2003-02-01), Link et al.
patent: 6649603 (2003-11-01), Lum
patent: 2005/0020481 (2005-01-01), Bain et al.
patent: 2005/0026993 (2005-02-01), Beatch et al.
patent: 2005/0038256 (2005-02-01), Barrett et al.
patent: 2005/0070552 (2005-03-01), Fedida et al.
patent: 2005/0119315 (2005-06-01), Fedida et al.
patent: 1234808 (1988-04-01), None
patent: 1235122 (1988-04-01), None
patent: 2004575 (1990-06-01), None
patent: 2058502 (1993-06-01), None
patent: 2172513 (1995-03-01), None
patent: 2240728 (1997-09-01), None
patent: 2008391 (1997-12-01), None
patent: 2289055 (1999-01-01), None
patent: 2268590 (2000-10-01), None
patent: 2132841 (2001-03-01), None
patent: 2 259 260 (1974-06-01), None
patent: 2 658 401 (1978-07-01), None
patent: 3 517 901 (1985-12-01), None
patent: 0147085 (1985-07-01), None
patent: 0222533 (1987-05-01), None
patent: 0147085 (1990-03-01), None
patent: 0372466 (1990-06-01), None
patent: 0380063 (1990-08-01), None
patent: 0380063 (1993-07-01), None
patent: 0552386 (1993-07-01), None
patent: 0720605 (2001-12-01), None
patent: 215963 (1995-02-01), None
patent: 02-270864 (1990-11-01), None
patent: WO 93/19056 (1993-09-01), None
patent: WO 94/07843 (1994-04-01), None
patent: WO 94/14435 (1994-07-01), None
patent: WO 95/08544 (1995-03-01), None
patent: WO 95/28155 (1995-10-01), None
patent: WO 96/18615 (1996-06-01), None
patent: WO 96/23894 (1996-08-01), None
patent: WO 97/32857 (1997-09-01), None
patent: WO 97/49680 (1997-12-01), None
patent: WO 99/02159 (1999-01-01), None
patent: WO 99/03468 (1999-01-01), None
patent: WO 99/11252 (1999-03-01), None
patent: WO 99/16431 (1999-04-01), None
patent: WO 99/50205 (1999-10-01), None
patent: WO 99/50225 (1999-10-01), None
patent: WO 00/47547 (2000-08-01), None
patent: WO 00/51981 (2000-09-01), None
patent: WO 01/96335 (2001-12-01), None
patent: WO 03/105756 (2003-12-01), None
patent: WO 2004/008103 (2004-01-01), None
patent: WO 2004/098525 (2004-11-01), None
patent: WO 2004/099137 (2004-11-01), None
Abstract of DE 2 259 260, Derwent World Patents Index, Jun. 6, 1974.
Abstract of JP 02-270864, espacenet database, Nov. 5, 1990.
Adcock, J.J. et al., (2003) “RSD931, a novel anti-tussive agent acting on airway sensory nerves” Br J Pharm, 138:407-416.
Altria, Kevin D. et al., (2001) “Capillary Electrophoresis as a Routine Analytical Tool in Pharmaceutical Analysis” LCGC 19(9): 972-985.
Arnin et al., (1996) “RPR 101821, a New Potent Cholesterol-lowering Agent: Inhibition of Squalene Synthase and 7-Dehydrocholesterol Reductase”, Naunyn-Schmiedeberg's Arch Pharmacol 353:233-240.
Bain et al., (1997) “Better Antiarrhythmics? Development of Antiarrhythmic Drugs Selective for Ischaemia-Dependent Arrhythmias”, Drug Development Research 42:198-210.
Barret, T. D. et al., (1996) “Glibenclarnide Possesses Transient, Ischaemia Selective Class III Antiarrhythmic Actions But does not Prevent Ischaemic Arrhythmias” BPS Proceedings 116P.
Barrett, T. D. et al., (1997) “A model of myocardial ischemia for the simultaneous assessment of electrophysiological changes and arrhythmias in intact rabbits” J Pharmacol Toxicol Methods, 37:27-36.
Barrett, T.D. (2000) “Ischaemia selectivity confers efficacy for suppression of ischaemia-induced arrhythmias in rats” Eur J Pharm, 398:365-374.
Barrett, T.D. et al., (1996) “Atypical Dose Response curves for Antiarrhythmic Drugs” BPS Proceedings 115P.
Barrett, Terrance D. (1997) “Ischemia Selective Electrophysiological and antiarrhythmic actions of RSD1019 in ischemic cardiac tissue” J Mol Cell Cardiol, pp. 197.
Barrett, Terrance D. et al., (2000) “RSD 1019 suppresses ischaemia-induced monophasic action potential shortening and arrhythmias in anaesthetized rabbits” Br J Pharm, 131.405-414.
Beatch et al., (2002) “RSD1235 Selectively Prolongs Atrial Refractoriness and Terminates AF in Dogs with Electricially Remodeled Atria”, Pharmacologist, 44(2) (Supplement I), A15: XIVthWorld Congress of Pharmacology: Meeting Abstracts.
Beatch, G. et al., “Effect of a Novel Anti-tussive Compound CP1 Against Citric Acid Induced Cough in Guinea-Pigs”Proc West Pharmacol Soc, 2001.
Beatch, G. N. et al., “RSD1235, A Novel Atrial-Selective Antiarrhythmic Drug, Shows Rapid and Extensive Oral Absorption in Man” 12thInternational Congress on Cardiovascular Pharmacotherapy, May 7-10, 2003, Barcelona, Spain.
Beatch, G. N. et al., (2002) “Ventricular Fibrillation, and Uncontrolled Arrhythmia Seeking New Targets” Drug Develop Res 55: 45-52.
Beatch, G.N. et al., (1996) “Antihistamine-induced Ventricular Arrhythmias” BPS Proceedings 120P.
Beatch, G.N. et al., (1997) “Characterization of a Non-Human Primate Model of Drug-Induced Torsades De Pointes” Proc. West. Pharmacol. Soc., 40: 13-16.
Beatch, G.N. et al., (2002) “RSD1235 Selectively Prolongs Atrial Refractoriness and Terminates AF in Dogs with Electrically Remodeled Atria” PACE 24(Part II):698. Abstract 702.
Bian et al., (1998)“Effects of K-opioid receptor stimulation in the heart and the involvement of protein kinase C” Brit. J. Pharmacol. 124:600-606.
Billman, (2003) “RSD-1235 Cardiome”, Current Opinion Investigational Drugs 4(3):352-354.
Boiadjiev et al., (1996) “pH-Sensitive Exciton Chirality Chromophore..Solvatochromic Effects on Circular Dichroism Spectra”, Tetrahedron: Asymmetry 7(10):2825-2832.
Bowen et al., (1992)“Characterization of the enantiomers of cis-n-[2-(3,4-Dichlorophenyl)Ethyl]-N-Methyl-2-(1-Pyrrolidinyl)Cyclohexylamine (BD737 and BD738): Novel Compounds with Highy Affinity, Selectivity and Biological Efficacy at Sigma Receptors” J. Pharmacol. Exp. Ther. 262(1):32-40.
Cardiome Drug Effective for Heart Patients. Press Release Sep. 3, 2002, 3 pages.
Cardiome Pharma Completes Phase I Safety Study. New Release Transmitted By CNN Newswire, Jul.30, 2001. 2 pages.
Cardiome Pharma Corp. Healthcare (Underweight) Company Report Dec. 12, 2002. 26 pages.
Cardiome Reports Dosing of First Patient in Pivotal Phase II Study. Press Release Jan. 17, 2002. 3 pages.
Cardiome Reports Oral Absorption of RSD1235 in Humans. News Release via Canada Newswire (2002).3 pages.
Clohs, L. et al., (2002) “Validation of a capillary electrophoresis assay for assessing the metabolic stability of veraparnil in human liver microsomes” J Cap Elec & Microch

Affiliated with

Also associated with

Rating

Ion channel modulating compounds and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ion channel modulating compounds and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ion channel modulating compounds and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3635920